Subscribe
istock-508496956cosmin4000
cosmin4000 / iStockphoto.com
28 May 2019Biotechnology

University of California granted fifth CRISPR patent

The US Patent and Trademark Office (USPTO) has issued a new CRISPR/Cas9 patent to the University of California ( UC), the University of Vienna and microbiologist Emmanuelle Charpentier.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Charpentier granted new CRISPR/Cas9 patent
23 April 2019   ERS Genomics has announced a new CRISPR/Cas9 US patent for use of the gene-editing technology in a single guide format.
Big Pharma
PeriRx sanctioned over false negotiation claims in patent suit
24 January 2022   PeriRx has been hit with sanctions over its conduct after its breach of licensing suit failed in a patent licensing dispute against the University of California.


Editor's picks

Americas
Fed Circ ruling on Wuhan import ban shakes up economic prong analysis
11 February 2025

Editor's picks

Americas
Fed Circ ruling on Wuhan import ban shakes up economic prong analysis
11 February 2025
Careers
Bristows appoints Irish patent attorney to boost UPC representation
4 February 2025
Americas
New national rankings recognise top US patent firms and lawyers
4 February 2025
Europe
UK court upholds EU SPC precedent, rejecting MSD’s appeal
30 January 2025
Americas
ADCs, TCR, and multimodal AI: Transformative trends in 2025
23 January 2025
Americas
Trump nixes Biden’s Executive Order on drug pricing
21 January 2025

More on this story

Americas
Charpentier granted new CRISPR/Cas9 patent
23 April 2019   ERS Genomics has announced a new CRISPR/Cas9 US patent for use of the gene-editing technology in a single guide format.
Big Pharma
PeriRx sanctioned over false negotiation claims in patent suit
24 January 2022   PeriRx has been hit with sanctions over its conduct after its breach of licensing suit failed in a patent licensing dispute against the University of California.

More on this story

Americas
Charpentier granted new CRISPR/Cas9 patent
23 April 2019   ERS Genomics has announced a new CRISPR/Cas9 US patent for use of the gene-editing technology in a single guide format.
Big Pharma
PeriRx sanctioned over false negotiation claims in patent suit
24 January 2022   PeriRx has been hit with sanctions over its conduct after its breach of licensing suit failed in a patent licensing dispute against the University of California.

More features

Hikma warns SCOTUS of ‘imminent threat’ for generic competition under ‘skinny label’ rules
Gilead deal staves off generic HIV drugs for another six years
Apple voids Omni MedSci wearable tech patent
Clifford Chance expands life sciences team with A&O Shearman hire
Vidal: ‘Erroneous’ jury instructions need to be fixed at Fed Circ
'A very good decision’: Patent industry welcomes UPC in-house reps update
Make a difference: Cast your vote in IP Diversity & Inclusion Awards 2025
Courtroom report: Regeneron’s $6bn biosimilar battle against Mylan